UPITT Program for Pharmaceutical Outcomes Research in Aging

UPITT 衰老药物结果研究计划

• 批准号: 7738644
• 负责人: JOSEPH T HANLON
• 金额: $ 8.96万
• 依托单位: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-30 至 2014-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7738644
• 关键词: Active Learning; Address; Advisory Committees; Age; Aging; Americas; Area; Award; Biometry; Businesses; Clinical; Clinical Pharmacology; Commit; Complex; Data; Data Set; Discipline; Disease; Doctor of Philosophy; Educational workshop; Elderly; Epidemiology; Event; Faculty; Foundations; Funding; Future; Gerontology; Goals; Grant; Health; Health Professional; Health Services Research; Healthcare; Healthcare Systems; Human Resources; Ice; Institute of Medicine (U.S.); Institutes; Instruction; Interest Group; Intervention; Knowledge; Leadership; Medical; Medication Errors; Medicine; Mentors; Methods; Outcome; Outcomes Research; Patients; Pharmaceutical Preparations; Pharmacologic Substance; Pharmacotherapy; Pharmacy facility; Population; Postdoctoral Fellow; Quality of life; Recruitment Activity; Reporting; Research; Research Design; Research Infrastructure; Research Personnel; Research Training; Resources; Safety; Secure; Seminal; Series; Societies; Solid; Students; Supervision; Symptoms; Training; Training Programs; Translating; Translational Research; Visit; aged; biomedical informatics; career; clinical practice; data management; experience; functional status; improved; investigator training; meetings; member; multidisciplinary; older patient; patient safety; pre-doctoral; prevent; programs; skills; success; teacher

DESCRIPTION (provided by applicant): The overall goal of this K07 is to build a strong research and research training Pharmaceutical Outcomes Research in Aging (PORA on the strong foundation of resources at UPITT. The PORA specific aims are to: 1) create an educational series that builds a solid foundation of knowledge and skills in geriatric pharmaceutical outcomes research; 2) build a cadre of well trained investigators in the field; and 3) provide experiential learning and support for data management and analysis of pharmaceutical data. In support of aim one, we will develop and provide: 1) a new 9 credit Area of Concentration in Geriatric Pharmaceutical Outcomes Research as part of the Clinical and Translational Science Institute's (CTSI) certificate, masters and PhD graduate programs; 2) a credit bearing monthly geriatric pharmaceutical outcomes research seminar, 3) an annual Visiting Professorship; and 4) an annual pre-meeting workshop on Geriatric Pharmaceutical Outcomes Research at the annual Gerontological Society of America meeting. In support of aim two, I have assembled a group of senior and junior faculty mentors. Trainees will be recruited at multiple levels (junior faculty, post doctoral fellows, residents, and pre-doctoral student trainees), come from multiple disciplines including pharmacy, medicine, epidemiology, health services research and other fields and be supported through existing funding from our affiliated health care systems (UPMC and VA), the CTSI, Pepper Center and our NIA training grants. We will annually also offer a small pilot award. In support of aim three, a senior biostatistician faculty member will provide study design and statistical support for the above- mentioned trainees. An Executive Committee consisting of the PI, the biostatistician and the PI of the NIA- funded Pepper Center and T32 and T35 programs will provide administrative and intellectual leadership. The PORA will be overseen by a multidisciplinary Internal Advisory Committee to assure that the PORA is well integrated with and leverages UPITT resources including the CTSI. The candidate is a leader in the field of geriatric pharmacotherapy research and a committed teacher and mentor to beginning investigators. The long term goal of this K07 proposal is to secure a T32 and/or center/program grant to train future researchers to conduct important research to enhance the health of older adults by improving the safety and use of medications. There is strong institutional support for the PORA to assure its short and long term success. RELEVANCE (See instructions): Older patients represent a rapidly increasing segment of the population that commonly experiences medication-related problems. New investigators and additional multidisciplinary pharmaceutical outcomes research are needed to detect, better understand, prevent or reduce, medication-related problems in older adults.

描述（由申请人提供）：该K07的总体目标是在衰老中建立强大的研究和研究培训药物研究结果（Pora在UPITT的强大资源基础上。Pora特定的目的是：1）创建一个教育系列，以建立一个稳固的知识和技能基础，这些基础是Geriatric Pharmaceutical Parmaceutical Compeces comesses ersemess erses ersess; 2）在该领域建立了训练有素的调查人员的干部； 3）为数据管理和药物数据分析提供体验学习和支持。为了支持AIM ONE，我们将开发和提供：1）作为临床和转化科学学院（CTSI）证书，硕士和博士研究生课程的一部分，老年制药成果研究的新9个学分集中。 2）每月老年药成果研究研讨会，3）年度访问教授职位； 4）在美国年度老年学会会议上，举办了关于老年药物结果研究的年度会议前研讨会。为了支持AIM二，我聚集了一群高级和初级教师导师。学员将在多个级别（初级教师，博士后研究员，居民和博士前的学生学员）中招募，来自多个学科，包括药房，医学，流行病学，卫生服务研究和其他领域，并通过我们的分支机构医疗保健系统（UPMC和VA），Peper pepper，Pepper Center和我们的NIAIA和我们的NIAIA niy niy niy niy niy niy and niy niy and niy and trains and nia trains and niy trains and niy trains and niy trains and niy trains and trains and niy trains。我们每年还将提供小型飞行员奖。为了支持AIM三，一位高级生物统计学家教师将为上述受训者提供研究设计和统计支持。由PI，生物统计学家和NIA资助的Pepper中心以及T32和T35计划组成的执行委员会将提供行政和知识领导。 PORA将由多学科的内部咨询委员会监督，以确保Pora与包括CTSI在内的Upitt Resources已充分融合并利用了Pora。该候选人是老年药物治疗研究领域的领导者，也是开始研究人员的忠实老师和导师。该K07提案的长期目标是获得T32和/或中心/计划赠款，以培训未来的研究人员，以进行重要的研究，以改善药物的安全性和使用，从而提高老年人的健康状况。 Pora有很大的机构支持，以确保其短期和长期的成功。相关性（请参阅说明）：老年患者代表了通常经历与药物有关的问题的人群的迅速增加。需要新的研究人员和其他多学科药物成果研究，以检测，更好地理解，预防或减少老年人与药物有关的问题。